Regionally distinct patterns of calpain activation and traumatic axonal injury following contusive brain injury in immature rats

Developmental Neuroscience

Volumn 28, Issue 4-5, 2006, Pages 466-476

  Huh, Jimmy W ^a   Franklin, Michael A ^b   Widing, Ashley G ^b   Raghupathi, Ramesh ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Amyloid precursor protein; Calpains; Closed head injury; Pediatric traumatic brain injury; Traumatic axonal injury

Indexed keywords

AMYLOID PROTEIN; CALPAIN;

AGE DISTRIBUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS CALLOSUM; DISEASE ASSOCIATION; ENZYME ACTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; THALAMUS; TRAUMATIC BRAIN INJURY; WHITE MATTER;

AGING; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANIMALS, NEWBORN; AXONS; BIOLOGICAL MARKERS; BRAIN; BRAIN INJURIES; CALPAIN; CELL DEATH; CEREBRAL INFARCTION; DENDRITES; DIFFUSE AXONAL INJURY; DISEASE MODELS, ANIMAL; NERVE DEGENERATION; RATS; UP-REGULATION;

EID: 33748209663     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094172     Document Type: Article

References (36)

1. Langlois JA, Kegler SR, Butler JA, Gotsch KE, Johnson RL, Reichard AA, Webb KW, Coronado VG, Selassie AW, Thurman DJ: Traumatic brain injury-related hospital discharges. Results from a 14-state surveillance system, 1997. MMWR Surveill Summ 2003;52:1-20.
2. Adelson PD, Kochanek PM: Head injury in children. J Child Neurol 1998;13:2-15.
3. Koskiniemi M, Kyykka T, Nybo T, Jarho L: Long-term outcome after severe brain injury in preschoolers is worse than expected. Arch Pediatr Adolesc Med 1995;149:249-254.
4. Luerssen TG, Klauber MR, Marshall LE: Outcome from head injury related to patient's age: a longitudinal prospective study of adult and pediatric head injury. J Neurosurg 1988;68:409-416.
5. Ribas GC, Jane JA: Traumatic contusions and intracerebral hematomas. J Neurotrauma 1992;9(suppl 1):S265-S278.
6. Zimmerman RA, Bilaniuk LT: Computed tomography in pediatric head trauma. J Neuroradiol 1981;8:257-271.
7. Wilde EA, Hunter JV, Newsome MR, Scheibel RS, Bigler ED, Johnson JL, Fearing MA, Cleavinger HB, Li X, Swank PR, Pedroza C, Roberson GS, Bachevalier J, Levin HS: Frontal and temporal morphometric findings on MRI in children after moderate to severe traumatic brain injury. J Neurotrauma 2005;22:333-344.
8. Duhaime AC, Christian CW, Rorke LB, Zimmerman RA: Nonaccidental head injury in infants - the 'shaken-baby syndrome'. N Engl J Med 1998;338:1822-1829.
9. Kampfl A, Posmantur RM, Zhao X, Schmutzhard E, Clifton GL, Hayes RL: Mechanisms of calpain proteolysis following traumatic brain injury: implications for pathology and therapy: a review and update. J Neurotrauma 1997;14:121-134.
10. Wang KK, Yuen PW: Calpain inhibition: an overview of its therapeutic potential. Trends Pharmacol Sci 1994;15:412-419.
11. Saatman KE, Bozyczko-Coyne D, Marcy V, Siman R, McIntosh TK: Prolonged calpain-mediated spectrin breakdown occurs regionally following experimental brain injury in the rat. J Neuropathol Exp Neurol 1996;55:850-860.
12. Newcomb JK, Kampfl A, Posmantur RM, Zhao X, Pike BR, Liu SJ, Clifton GL, Hayes RL: Immunohistochemical study of calpain-mediated breakdown products to alpha-spectrin following controlled cortical impact injury in the rat. J Neurotrauma 1997;14:369-383.
13. Saatman KE, Abai B, Grosvenor A, Vorwerk CK, Smith DH, Meaney DF: Traumatic axonal injury results in biphasic calpain activation and retrograde transport impairment in mice. J Cereb Blood Flow Metab 2003;23:34-42.
14. Buki A, Siman R, Trojanowski JQ, Povlishock JT: The role of calpain-mediated spectrin proteolysis in traumatically induced axonal injury. J Neuropathol Exp Neurol 1999;58:365-375.
15. McCracken E, Hunter AJ, Patel S, Graham DI, Dewar D: Calpain activation and cytoskeletal protein breakdown in the corpus callosum of head-injured patients. J Neurotrauma 1999;16:749-761.
16. Siman R, Card JP, Davis LG: Proteolytic processing of beta-amyloid precursor protein by calpain I. J Neurosci 1990;10:2400-2411.
17. Koo EH, Sisodia SS, Archer DR, Martin LJ, Weidemann A, Beyreuther K, Fischer P, Masters CL, Price DL: Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc Natl Acad Sci USA 1990;87:1561-1565.
18. Stone JR, Singleton RH, Povlishock JT: Antibodies to the C-terminus of the beta-amyloid precursor protein (APP): a site specific marker for the detection of traumatic axonal injury. Brain Res 2000;871:288-302.
19. Buki A, Farkas O, Doczi T, Povlishock JT: Preinjury administration of the calpain inhibitor MDL-28170 attenuates traumatically induced axonal injury. J Neurotrauma 2003;20:261-268.
20. Saatman KE, Zhang C, Bartus RT, McIntosh TK: Behavioral efficacy of posttraumatic calpain inhibition is not accompanied by reduced spectrin proteolysis, cortical lesion, or apoptosis. J Cereb Blood Flow Metab 2000;20:66-73.
21. Saatman KE, Murai H, Bartus RT, Smith DH, Hayward NJ, Perri BR, McIntosh TK: Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat. Proc Natl Acad Sci USA 1996;93:3428-3433.
22. Posmantur R, Kampfl A, Siman R, Liu J, Zhao X, Clifton GL, Hayes RL: A calpain inhibitor attenuates cortical cytoskeletal protein loss after experimental traumatic brain injury in the rat. Neuroscience 1997;77:875-888.
23. Pohl D, Bittigau P, Ishimaru MJ, Stadthaus D, Hubner C, Olney JW, Turski L, Ikonomidou C: N-methyl-D-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain. Proc Natl Acad Sci USA 1999;96:2508-2513.
24. Blomgren K, Kawashima S, Saido TC, Karlsson JO, Elmered A, Hagberg H: Fodrin degradation and subcellular distribution of calpains after neonatal rat cerebral hypoxic-ischemia. Brain Res 1995;684:143-149.
25. Rice D, Barone S: Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 2000;108:511-533.
26. Yager JY, Thornhill JA: The effect of age on susceptibility to hypoxic-ischemic brain damage. Neurosci Biobehav Rev 1997;21:167-174.
27. Dobbing J: The later development of the brain and its vulnerability; in Davis JA, Dobbings J (eds): Scientific Foundations of Pediatrics. London, Heinemann Medical, 1981, pp 744-759.
28. Roberts-Lewis JM, Savage MJ, Marcy VR, Pinsker LR, Siman R: Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic gerbil brain. J Neurosci 1994;14:3934-3944.
29. Dixon CE, Clifton GL, Lighthall JW, Yaghmai AA, Hayes RL: A controlled cortical impact model of traumatic brain injury in the rat. J Neurosci Methods 1991;39:253-262.
30. 45calcium accumulation following lateral fluid percussion: acute and delayed patterns. J Neurotrauma 2001;18:141-162.
31. Rothman SM, Olney JW: Excitotoxicity and the NMDA receptor. Trends Neurosci 1987; 10:299-302.
32. Pierce JE, Trojanowski JQ, Graham DI, Smith DH, McIntosh TK: Immunohistochemical characterization of alterations in the distribution of amyloid precursor proteins and beta-amyloid peptide after experimental brain injury in the rat. J Neurosci 1996;16:1083-1090.
33. Hamakubo T, Kannagi R, Murachi T, Matus A: Distribution of calpains I and II in rat brain. J Neurosci 1986;6:3103-3111.
34. Kirazov E, Kirazov L, Bigl V, Schliebs R: Ontogenic changes in protein level of amyloid precursor protein (APP) in growth cones and synaptosomes from rat brain and prenatal expression pattern of APP mRNA isoforms in developing rat embryo. Int J Dev Neurosci 2001;19:287-296.
35. Chen M, Fernandez HL: Mu-calpain is functionally required for alpha-processing of Alzheimer's beta-amyloid precursor protein. Biochem Biophys Res Commun 2005;330:714-721.
36. Raghupathi R: Cell death mechanisms following traumatic brain injury. Brain Pathol 2004;14:215-222.